---
title: "Regeneron makes $80M obesity deal with Hansoh"
date: Mon, 02 Jun 2025 15:11:14 +0000
source: "EndpointsNews"
link: "https://endpoints.news/regeneron-makes-80m-obesity-deal-with-hansoh/"
---

Regeneron has followed in Merck’s footsteps by licensing an obesity candidate from the China-based biotech Hansoh Pharma. But Regeneron got a much more advanced candidate — and for less.

 The US company will pay $80 million ...